dijous, 26 de març del 2015

InVivo adds 3rd site to clinical trial




InVivo Therapeutics adds a 3rd clinical site to a feasibility study of its biodegradable implant to treat acute spinal cord injuries.








read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1D20lZp

Cap comentari:

Publica un comentari a l'entrada